Search hospitals > Florida > Saint Petersburg
Florida Cancer Specialists
Claim this profileSaint Petersburg, Florida 33705
Global Leader in Non-Small Cell Lung Cancer
Global Leader in Breast Cancer
Conducts research for Lung Cancer
Conducts research for Cancer
Conducts research for Tumors
144 reported clinical trials
12 medical researchers
Summary
Florida Cancer Specialists is a medical facility located in Saint Petersburg, Florida. This center is recognized for care of Non-Small Cell Lung Cancer, Breast Cancer, Lung Cancer, Cancer, Tumors and other specialties. Florida Cancer Specialists is involved with conducting 144 clinical trials across 115 conditions. There are 12 research doctors associated with this hospital, such as Vijay Patel, Gail L Wright, MD, Sunil Gandhi, MD, and Maen Hussein.Area of expertise
1Non-Small Cell Lung Cancer
Global LeaderStage IV
Stage III
MDM2
2Breast Cancer
Global LeaderStage IV
Stage III
HER2 negative
Top PIs
Vijay PatelFlorida Cancer Specialists4 years of reported clinical research
Studies Lung Cancer
Studies Non-Small Cell Lung Cancer
17 reported clinical trials
36 drugs studied
Gail L Wright, MDFlorida Cancer Specialists - North Region4 years of reported clinical research
Studies Breast Cancer
Studies Colorectal Cancer
9 reported clinical trials
19 drugs studied
Sunil Gandhi, MDFlorida Cancer Specialists3 years of reported clinical research
Studies Breast Cancer
Studies Lymphoma
6 reported clinical trials
17 drugs studied
Maen HusseinFlorida Cancer Specialists - North Division1 year of reported clinical research
Studies Cancer
Studies Non-Small Cell Lung Cancer
5 reported clinical trials
10 drugs studied
Clinical Trials running at Florida Cancer Specialists
Non-Small Cell Lung Cancer
Breast Cancer
Lung Cancer
Lymphoma
Follicular Lymphoma
Chronic Lymphocytic Leukemia
Chronic B-Cell Leukemia
Small Cell Lung Cancer
Mantle Cell Lymphoma
Cancer
Dato-DXd + Pembrolizumab
for Non-Small Cell Lung Cancer
This study is designed to assess the efficacy and safety of datopotamab deruxtecan (Dato-DXd) in combination with pembrolizumab versus pembrolizumab in combination with pemetrexed and platinum chemotherapy in participants with no prior therapy for advanced or metastatic non-squamous non-small cell lung cancer (NSCLC).
Recruiting2 awards Phase 312 criteria
Selpercatinib
for Non-Small Cell Lung Cancer
This trial is testing if the drug selpercatinib can safely and effectively prevent lung cancer from returning in patients who have had treatment. It focuses on people with early-stage lung cancer. The drug works by blocking proteins that help cancer cells grow.
Recruiting1 award Phase 38 criteria
Targeted Therapy
for Lung Cancer
This is a phase 2/3, global, multicenter, open-label, multi-cohort study designed to evaluate the safety and efficacy of targeted therapies or immunotherapy as single agents or in combination in participants with unresectable, advanced or metastatic NSCLC determined to harbor oncogenic somatic mutations or positive by tumor mutational burden (TMB) assay as identified by a blood-based next-generation sequencing (NGS) circulating tumor DNA (ctDNA) assay.
Recruiting1 award Phase 2 & 37 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Florida Cancer Specialists?
Florida Cancer Specialists is a medical facility located in Saint Petersburg, Florida. This center is recognized for care of Non-Small Cell Lung Cancer, Breast Cancer, Lung Cancer, Cancer, Tumors and other specialties. Florida Cancer Specialists is involved with conducting 144 clinical trials across 115 conditions. There are 12 research doctors associated with this hospital, such as Vijay Patel, Gail L Wright, MD, Sunil Gandhi, MD, and Maen Hussein.